"CYNA is now well funded, NASDAQ-listed and liquid; it isdefinitely among my better ideas as of today." (7/8/15) Cynapsus Therapeutics Inc. - The Life Sciences Report Interview with Jason Napodano More >
Subscribe to Streetwise Reports’ Newsletters
Receive weekly insight into today’s investment ideas from leading analysts and experts.
To make sure our emails arrive in your inbox, please add email@example.com to your "safe sender" list. If you are unsure how to whitelist or add someone to your safe senders list, please follow the instructions here.
"If results from RVX's Phase 3 program are positive, the stock could have a significant revaluation to much higher levels." (7/8/15) Resverlogix Corp. - The Life Sciences Report Interview with Jason Napodano More >
"INO has a broad platform that includes an IL-12 DNA vaccine and other DNA vaccines for both cancer and infectious diseases." (6/24/15) Inovio Pharmaceuticals Inc. - The Life Sciences Report Interview with George Zavoico More >